The FDA has approved Zevaskyn, the first gene-modified cellular therapy for treating wounds in patients with recessive dystrophic epidermolysis bullosis, a rare genetic skin disorder. Made by Abeona ...

Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...

The U.S. Food and Drug Administration has approved Abeona Therapeutics' Zevaskyn (prademagene zamikeracel) for patients with ...

People with xeroderma pigmentosum can severely burn within minutes of being in the sun and are thousands of times more likely ...

Barely a year after the U.S. FDA shackled Abeona Therapeutics Inc.’s cell-based gene therapy with a complete response letter, the agency has approved it for treating a rare and genetic skin disease.

Gluten might appear harmless, but for some individuals, it can silently provoke significant health problems. Often lacking ...

Celiac Disease Drugs Market size, trends and growth forecast 2035, advancements in drug development, key market dynamics, and regional trends ...

The three of these conditions are celiac disease (damage to the small intestine), dermatitis herpetiformis (damage to the skin), and gluten ataxia (damage to the brain). When you have gluten ataxia, ...

Unlike non-celiac gluten sensitivity, celiac disease is a serious condition that, without treatment, can damage the intestines. The main treatment for celiac disease is following a gluten-free diet.

Gluten-related disorders, including celiac disease, non-celiac gluten sensitivity, and wheat allergy, impact millions globally, with varying symptoms and prevalence.

An estimated 16 million Americans have rosacea — a common skin condition that causes the face to appear red or flushed. While the ailment typically affects middle-aged women, President Trump’s ...

Eczema is a chronic inflammatory skin condition caused by hypersensitivity to certain irritants, such as soaps, detergents, and other products. Dry, itchy skin due to menopause can cause eczema to ...